Previous 10 | Next 10 |
Inseego Corp., a leader in 5G edge cloud solutions, today announced it has appointed experienced technology executive Philip Brace to its board of directors as an independent director. “We are delighted to welcome Phil to our board of directors,” said Jeff Tuder, Chair of Inseeg...
Inseego Corp., a leader in 5G edge cloud solutions, today announced the appointment of Steven Gatoff as Chief Financial Officer, effective September 14, 2023. Mr. Gatoff will succeed Robert G. Barbieri, who will be stepping down from the CFO role to pursue his desire to return to his consulting b...
2023-09-12 18:09:08 ET Inovio Pharmaceuticals, Inc. (INO) H.C. Wainwright 25th Annual Global Investment Conference Call September 12, 2023, 04:30 PM ET Company Participants Jacqueline Shea - President and Chief Executive Officer Conference Call Participants L...
2023-09-09 01:35:29 ET Summary Inovio Pharmaceuticals is working on DNA-based immunotherapy platforms. One of their drugs is set to enter phase 3 trials for a rare indication. They have more cash on hand than the market cap, and have tightened up the ship considerably since la...
2023-09-07 09:03:41 ET More on Inovio Seeking Alpha’s Quant Rating on Inovio Pharmaceuticals Historical earnings data for Inovio Pharmaceuticals Financial information for Inovio Pharmaceuticals Inovio Pharmaceuticals, Inc. ( INO ) Q2 2023 Earning...
INOVIO Announces U.S. FDA Breakthrough Therapy Designation Granted for INO-3107 for the Treatment of Recurrent Respiratory Papillomatosis PR Newswire • Designation based on clinical evidence indicating INO-3107 may demonstrate substantial improvement over existing thera...
INOVIO to Present at the H.C. Wainwright 25th Annual Global Investment Conference PR Newswire PLYMOUTH MEETING, Pa. , Aug. 29, 2023 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat ...
2023-08-09 20:30:24 ET Image source: The Motley Fool. Inovio Pharmaceuticals (NASDAQ: INO) Q2 2023 Earnings Call Aug 09, 2023 , 4:30 p.m. ET Operator Continue reading For further details see: Inovio Pharmaceuticals (INO) Q2 2023 Earnings ...
2023-08-09 18:40:27 ET Inovio Pharmaceuticals, Inc. (INO) Q2 2023 Earnings Conference Call August 09, 2023, 04:30 PM ET Company Participants Thomas Hong - Manager of Investor Relations Jacque Shea - President and Chief Executive Officer Michael Sumner - Chief Med...
2023-08-09 16:07:50 ET Inovio Pharmaceuticals press release ( NASDAQ: INO ): Q2 GAAP EPS of -$0.13 beats by $0.01 . Revenue of $0.23M (-70.5% Y/Y) misses by $0.03M . For further details see: Inovio Pharmaceuticals GAAP EPS of -$0.13 beats by $0.01, revenu...
News, Short Squeeze, Breakout and More Instantly...
Inovio Pharmaceuticals Inc. Company Name:
INO Stock Symbol:
NASDAQ Market:
Inovio Pharmaceuticals Inc. Website:
2024-07-16 13:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
Inseego Corp. (Nasdaq: INSG), a technology leader in 5G mobile and fixed wireless solutions for mobile network operators, Fortune 500 enterprises and SMBs, today announced that the company will release its financial results for the second quarter of 2024, ended June 30, 2024, after the financial ...
INO-3107 Awarded the Innovation Passport Designation Under U.K. Government's Innovative Licensing and Access Pathway PR Newswire Award recognizes the potential for INO-3107 to be the first therapeutic option in the United Kingdom for patients suffering from Recurrent Respi...